[PSYCHODYSLEPTIC MANIFESTATIONS APPEARING IN THE COURSE OF TREATMENTS WITH PSYCHOLEPTICS].
D000654:Amobarbital; D001463:Barbiturates / Q000633:toxicity*; D001714:Bipolar Disorder; D002389:Catatonia; D002746:Chlorpromazine; D003975:Diazepam; D006212:Hallucinations; D006801:Humans; D010640:Phenothiazines; D011346:Prochlorperazine; D011605:Psychoses, Substance-Induced; D011618:Psychotic Disorders; D012110:Reserpine; D014116:Toxicology
D001463:Barbiturates; D010640:Phenothiazines; D012110:Reserpine; C031637:phenothiazine; D000654:Amobarbital; D003975:Diazepam; D002746:Chlorpromazine; C032232:barbituric acid; D011346:Prochlorperazine; C084825:thioproperazine
AMOBARBITAL; BARBITURATE TOXICOLOGY; CATATONIA; CHLORPROMAZINE; DIAZEPAM; HALLUCINATIONS; PHENOTHIAZINES; PROCHLORPERAZINE; PSYCHOSES, MANIC-DEPRESSIVE; PSYCHOSES, TOXIC; RESERPINE; THIOPROPERAZINE; TOXICOLOGIC REPORT
MANIFESTATIONS PSYCHO-DYSLEPTIQUES APPARAISSANT AU COURS DE TRAITEMENTS PAR PSYCHOLEPTIQUES.